05/01/2025
8:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form NT 20-F | |
04/15/2025
8:05 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025
8:07 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
04/14/2025
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/31/2025
4:23 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-4/A | |
03/31/2025
9:24 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
03/31/2025
8:29 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
8:20 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
8:21 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
03/03/2025
5:40 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-4/A | |
02/27/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for NLSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025
7:02 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
02/14/2025
4:08 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:43 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
02/10/2025
6:57 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
02/10/2025
6:54 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025
5:45 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
01/31/2025
6:47 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:51 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/30/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025
9:46 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/28/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025
4:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/16/2025
8:20 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025
8:22 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/14/2025
3:27 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:04 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:14 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/07/2025
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:52 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:54 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/30/2024
5:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
12/23/2024
3:04 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
3:23 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
12/19/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
7:32 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/17/2024
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:32 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/10/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
12/03/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
11:15 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
11/21/2024
3:01 PM | Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/18/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
4:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:27 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/08/2024
3:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024
3:30 PM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
11/05/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
6:39 PM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
11/04/2024
5:20 PM | Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/04/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:02 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
10/28/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024
3:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
10/22/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
4:19 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/18/2024
3:31 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
12:24 PM | ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G | |
10/15/2024
8:09 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
6:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
4:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/26/2024
3:40 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
8:16 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/01/2024
7:26 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 424B5 | |
07/01/2024
7:09 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
3:54 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
11:15 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
06/25/2024
3:31 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:28 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
8:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
4:25 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
8:10 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy NLSP Stock Free NLSP Stock Alerts